- Associated Press - Wednesday, August 19, 2015

DES MOINES, Iowa (AP) - A pharmaceutical company will pay the state of Iowa more than $972,000 to settle allegations that it improperly marketed two of its medications.

The Iowa Attorney General’s Office announced the settlement Wednesday involving California-based Amgen Inc. It is part of a $72 million agreement with 48 states and the District of Columbia over allegations that the company unlawfully promoted the drugs Aranesp and Enbrel.

A petition filed Tuesday in district court in Polk County alleges Amgen violated Iowa’s consumer protection laws by promoting the drugs without federal approval for certain conditions and dosing frequencies.

Amgen is now barred from certain marketing strategies, including promoting off-label uses of the drugs to medical professionals.

The company said in a statement it was pleased to resolve the issue.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide